OncoSwab, founded in 2023, is a biotechnology startup dedicated to revolutionizing lung cancer detection. With the slogan, "Simplifying lung cancer detection," OncoSwab addresses a critical healthcare gap—75% of lung cancer cases are currently detected too late. Their innovative approach aims to provide a non-invasive, user-friendly testing method to catch the disease earlier.
The company is conducting proof-of-concept trials in collaboration with leading hospitals and lung cancer experts in the US and Europe, showcasing solid potential to impact global health positively. Backed by the Health Wildcatters Accelerator and the Swiss Government's DayOne Tech, OncoSwab received a Seed Round investment on 11 September 2023, further supported by several pre-seed investors.
With offices strategically located in San Francisco, California and Corroux, Switzerland, OncoSwab is well-positioned in the Biotechnology and Health Care industries, aiming to save lives through accessible early cancer detection solutions.
